alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```
[Federal Register Volume 60, Number 91 (Thursday, May 11, 1995)]
[Notices]
[Page 25242]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11586]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Division of Research Grants; Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Division of Research Grants Special Emphasis Panel (SEP) meetings:

Purpose/Agenda: To review individual grant applications
Name of SEP: Clinical Sciences
Date: June 2, 1995
Time: 12:00 noon
Place: NIH, Rockledge II, Room 4146 Telephone Conference
Contact Person: Dr. Martin Padarathsingh, Scientific Review Admin., 
6701 Rockledge Drive, Room 4146, Bethesda, MD 20891, (301) 594-7192

Name of SEP: Microbiological and Immunological Sciences
Date: June 2, 1995
Time: 12:00 noon
Place: NIH, Rockledge II, Room 4202 Telephone Conference
Contact Person: Dr. Howard Berman, Scientific Review Administrator, 
6701 Rockledge Drive, Room 4202, (301) 594-7234

Name of SEP: Microbiological and Immunological Sciences
Date: June 5, 1995
Time: 3:00 p.m.
Place: NIH, Rockledge II, Room 4206 Telephone Conference
Contact Person: Dr. Betty Hayden, Scientific Review Administrator, 
6701 Rockledge Drive, Room 4206, Bethesda, MD 20892, (301) 594-7310

Name of SEP: Microbiological and Immunological Sciences
Date: June 6, 1995
Time: 4:00 p.m.
Place: NIH, Rockledge II, Room 4206 Telephone Conference
Contact Person: Dr. Betty Hayden, Scientific Review Administrator, 
6701 Rockledge Drive, Room 4206, Bethesda, MD 20892, (301) 594-7310

Name of SEP: Multidisciplinary Sciences
Date: June 9, 1995
Time: 1:00 p.m.
Place: Rosslyn-Westpark, Arlington, VA
Contact Person: Dr. Lee Rosen, Scientific Review Administrator, 6701 
Rockledge Drive, Room 5116, Bethesda, MD 20892, (301) 594-7276.

    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: May 5, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-11586 Filed 5-10-95; 8:45 am]
BILLING CODE 4140-01-M
```
Order entered May 9, 2022 

In The 

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-22-00229-CV 

IN RE HEARTLAND EXPRESS, INC. OF IOWA, Relator 

Original Proceeding from the 95th District Court 

Dallas County, Texas 

Trial Court Cause No. DC-18-00697-D 

 ORDER 

Before Justices Osborne, Partida-Kipness, and Smith 

Based on the Court’s opinion of this date, we DENY relator’s petition for 

writ of mandamus. We also LIFT the stay issued by this Court’s March 18, 2022 

order. 

/s/ CRAIG SMITH 

 JUSTICE
AURORA LOAN SERVICES *A Lehman Brothers Company*Depositor: Structured Asset Securities Corporation 745 Seventh Avenue 8th Floor New York, NY 10019 Trustee:   U.S. Bank National Association  One Federal Street 3rd Floor  Boston, MA 02110 Securities Administrator: Subject: Annual Officer's Certification Fiscal Year:    2007 Securitization:  LMT 2007-8 I, E. Todd Whittemore, the undersigned, a duly authorized officer of Aurora Loan Services LLC (the "Master Servicer"), do certify the following for the Calendar Year 2007: 1.A review of the activities of the Master Servicer during the period beginning on the cut-off date and ending on December 31, 2007 (the "reporting period") and of its performance under the Agreement for such period has been made under my supervision. 2.To the best of my knowledge, based on such review, the Master Servicer has fulfilled all of its obligations under the Agreement in all material aspects throughout such reporting period. Certified by: AURORA LOAN SERVICES LLC By: /s/ E. Todd Whittemore Name:  E .   T odd Whittemore  Title: Executive Vice President
Donald Jamal WILSON, petitioner, v. UNITED STATES.

No. 12-9789.

Supreme Court of the United States

May 20, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
[Federal Register Volume 60, Number 95 (Wednesday, May 17, 1995)]
[Notices]
[Page 26445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12084]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Eye Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting:

    Name of Committee: Vision Research Review Committee.
    Date: June 5, 1995.
    Time: 8:00 a.m. until adjournment at approximately 6:00 p.m.
    Place: Holiday Inn Bethesda, Delaware Room, 8120 Wisconsin 
Avenue, Bethesda, MD 20814, (301) 652-2000.
    Contact Person: Lois DeNinno, Committee Management Officer, EPS 
350, 6120 Executive Blvd. MSC 7164, Bethesda, MD 20892-7164, 301/
496-5301.
    Purpose/Agenda: To review and evaluate grant applications.

    The meeting will be closed in accordance with the provisions set 
forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program No. 93.867, Vision 
Research; National Institutes of Health, HHS)

    Dated: May 10, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-12084 Filed 5-16-95; 8:45 am]
BILLING CODE 4140-01-M
I 

109TH CONGRESS 

1ST SESSION H. R. 1417 

To amend the Internal Revenue Code of 1986 to permanently extend the 

subpart F exemption for active financing income. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 17, 2005 

Mr. MCCRERY (for himself, Mr. NEAL of Massachusetts, Mr. SHAW, Mr. 

HERGER, Mr. SAM JOHNSON of Texas, Mr. ENGLISH of Pennsylvania, 

Mr. WELLER, Mr. HULSHOF, Mr. LEWIS of Kentucky, Mr. FOLEY, Mr. 

CANTOR, Ms. HART, Mr. BEAUPREZ, Mr. MCDERMOTT, Mr. JEFFERSON, 

Mr. BECERRA, and Mr. CROWLEY) introduced the following bill; which 

was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to permanently 

extend the subpart F exemption for active financing income. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PERMANENT SUBPART F EXEMPTION FOR AC4 TIVE FINANCING INCOME. 

5 (a) BANKING, FINANCING, OR SIMILAR BUSI6 NESSES.—Subsection (h) of section 954 of the Internal 

7 Revenue Code of 1986 (relating to special rule for income 
2 

•HR 1417 IH 

1 derived in the active conduct of banking, financing, or 

2 similar businesses) is amended by striking paragraph (9). 

3 (b) INSURANCE BUSINESSES.—Subsection (e) of sec4 tion 953 of such Code (relating to exempt insurance in5 come) is amended by striking paragraph (10) and by re6 designating paragraph (11) as paragraph (10). 

7 (c) EFFECTIVE DATE.—The amendments made by 

8 this section shall apply to taxable years of a foreign cor9 poration beginning after the date of the enactment of this 

10 Act, and to taxable years of United States shareholders 

11 with or within which such taxable years of such foreign 

12 corporation end. 

Æ
**
**EXHIBIT 31**

**CERTIFICATIONS**

I, NancyWillis, certify that: 

1. I have reviewed this quarterly report on Form 10-Q of Sabine RoyaltyTrust, for which Argent Trust Company acts as Trustee; 

2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all materialrespects the financial condition, distributable income and changes in trust corpus of the registrant as of, and for, the periods presented in this report; 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(c) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), or for causing such controls and procedures to be established and maintained, for the registrant and I have: 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under mysupervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to bedesigned under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report myconclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred duringthe registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to theregistrant’s auditors: 

a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in theregistrant’s internal control over financial reporting. 

 
By: /s/ Nancy Willis Nancy Willis Vice President Argent Trust Company
Date: November 7, 2023 
**
Exhibit 23.11


Consent of Independent Auditors





The Board of Directors


Kennedy-Wilson Holdings, Inc.:





We consent to the use of our report dated March 31, 2014, with respect to the balance sheet of WH Valle Di Oro 79, LLC as of December 31, 2013, the related statement of operations, members’ capital and cash flows for the year then ended, and the related notes to the financial statements, incorporated by reference in the registration statements (No. 333-174742, No. 333-175002, No. 333-175559, No. 333-184752, and No. 333-192059) on Form S-3, the registration statement (No. 333-164928) on Form S-8, the registration statement (No. 333-164926) on Form S-1/A and the registration statement (No. 333-186690) on Form S-4 of Kennedy-Wilson Holdings, Inc. in reliance upon the reports of KPMG LLP, independent auditors, which report appears in amendment no. 1 to the December 31, 2013 annual report on Form 10-K of Kennedy-Wilson Holdings, Inc.











/s/ KPMG LLP


Los Angeles, California


March 31, 2014
EX-33.2
MANAGEMENT'S ASSERTION ON COMPLIANCE
WITH REGULATION AB CRITERIA

March 6, 2008

SunTrust Bank (the "Asserting Party") is responsible for assessing compliance
with the servicing criteria set forth in Title 17, Section 229.1122(d)(2)(i),
229.1122(d)(4)(i) and 229.1122(d)(4)(ii) of the Code of Federal Regulations
(the "CFR") (the "Applicable Servicing Criteria"), for securitization
transactions serviced by SunTrust Mortgage, Inc. occurring after December 31,
2005 (the "Platform"). The Asserting Party is not assessing compliance with any
other criteria set forth in Section 229.1122(d) of the CFR.

The Asserting Party used the applicable criteria in paragraph (d) of Title 17,
Section 229.1122 of the CFR to assess compliance with the Applicable Servicing
Criteria.

The Asserting Party has concluded that it has complied, in all material
respects, with the Applicable Servicing Criteria as of and for the twelve month
period ending December 31, 2007 (the "Reporting Period").

Ernst & Young LLP, an independent registered public accounting firm, has issued
an attestation report on the assessment of compliance with the Applicable
Servicing Criteria for the Reporting Period as set forth in this assertion.


SUNTRUST BANK
Solely with respect to Sections 229.1122(d)(4)(i) and 229.1122(d)(4)(ii)


By: /s/ Rosealma T. Burton
Name: Rosealma T. Burton
Title: First Vice President


SUNTRUST BANK
Solely with respect to Section 229.1122(d)(2)(i)


By: /s/ Tomas E. Suarez
Name: Tomas E. Suarez
Title: Group Vice President
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Radiation Safety

Alerts and Notices Home
          Radiation-Emitting Products
          Radiation Safety
          Alerts and NoticesRadiation Safety Alerts and Notices
  	
        Share
    Post
    Linkedin

    Email
    PrintList of Notices

FDA Statement on Radiation Overexposures in Panama
	Consumer Safety Alert: Internet Sales of Laser Products
	Ultraviolet Radiation Burns from High Intensity Metal Halide and Mercury Vapor Lighting Remain a Public Health ConcernSafety Communications

FDA Safety Communication: Illegal Sale of Potentially Unsafe Hand-held Dental X-Ray Units
	Safety Communications

                                                                                  Content current as of:
      09/17/2018Alerts and Notices
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
Unassociated Document


    Exhibit
10.1

    


    



    


    


    January
26, 2009

    


    


    Shane
O’Leary

    4007
5th
Street SW

    Calgary,
AB T2S 2C9

    Canada

    


    


    Dear
Shane:

    


    I am
extremely pleased to offer you the position of Chief Operating Officer with Gran
Tierra Energy Inc.

    


    This
offer is conditional upon passing required background and reference
checks.  Your compensation will consist of an initial salary of
C$280,000 per year, an initial stock option grant of 500,000 options, five weeks
paid vacation, eligibility for an annual bonus payment and other compensation as
determined by the Board from time to time. This compensation has been approved
by the members of the Compensation Committee of the Board of Directors, but is
still subject to further approval of the full Board of Directors of Gran Tierra
Energy.

    


    Attached
is a copy of an Executive Employment Agreement for your review and, if you
agree, your signature.

    


    Gran
Tierra Energy has been extraordinarily successful in the first four years of its
history as a result of the dedication of a committed team of
people.  Our intent is to continue this track record of success and
growth into the future; we look forward to your acceptance of this employment
and share in the leadership of this outstanding growth story.

    


    


    Sincerely,

    


    


    /s/ Dana
Coffield

    


    Dana
Coffield

    President
and CEO
Raul JIMENEZ, petitioner, v. UNITED STATES.

No. 12-10003.

Supreme Court of the United States

May 28, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

WAYMO LLC,

Plaintiff,

 v.

UBER TECHNOLOGIES, INC.;

OTTOMOTTO LLC; and OTTO

TRUCKING LLC,

Defendants. /

No. C 17-00939 WHA

ORDER REQUIRING

DECLARATIONS

By SEPTEMBER 15 AT NOON, counsel for plaintiff Waymo LLC shall file a declaration

under oath responding to each and every accusation of discovery misconduct by Waymo set

forth at pages 1:23 to 2:13 of defendants Uber Technologies, Inc., and Ottomotto LLC’s

(collectively, “Uber”) response brief filed September 12 (Dkt. No. 1534). Respond fully to

each and every allegation therein. Be complete and accurate. Counsel shall also state the

extent, if any, to which it is true that Waymo “still has not produced a privilege log” (id. at 4).

Also by SEPTEMBER 15 AT NOON, counsel for Uber shall file a declaration under oath in

support of the aforementioned accusations.

IT IS SO ORDERED.

Dated: September 13, 2017. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:17-cv-00939-WHA Document 1536 Filed 09/13/17 Page 1 of 1
Damon Lamont HUGHES, petitioner, v. UNITED STATES.

No. 12-9409.

Supreme Court of the United States

April 22, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF INDIANA 

SOUTH BEND DIVISION 

UNITED STATES OF AMERICA

 VS. 

PEDRO CALDERA-PACHECO

) 

) 

) 

) 

) 

CAUSE NO. 3:13-CR-40-RLM

O R D E R 

No objections have been filed to the magistrate judge’s findings and 

recommendations upon a plea of guilty issued on May 29, 2013. Accordingly, 

the court ADOPTS those findings and recommendations (Doc. No. 28), 

ACCEPTS defendant Pedro Caldera-Pacheco’s plea of guilty, and FINDS the 

defendant guilty of Count 2 of the Indictment, in violation of 18 U.S.C. § 

924(c)(1)(A). 

SO ORDERED. 

 ENTERED: June 24, 2013 

 /s/ Robert L. Miller, Jr. 

 Judge 

 United States District Court
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

ASHWANI BHAKHRI,

Plaintiff,

v.

RAY RUIZ,

Defendant.

Case No. 17-cv-00740-WHO 

ORDER ADOPTING REPORT AND 

RECOMMENDATION AND 

REMANDING CASE

Re: Dkt. No. 7

On February 17, 2017, Magistrate Judge Jacqueline Scott Corley granted defendant’s 

application to proceed in forma pauperis and issued an Order to Show Cause, requiring defendant 

Ruiz to show cause why this removed unlawful detainer case should not be remanded to Alameda 

County Superior Court for lack of jurisdiction. Dkt. No. 5. Defendant did not file a response to 

the OSC and on March 23, 2017, Judge Corley issued a Report and Recommendation 

recommending that this case be remanded. 

Objections to Judge Corley’s recommendation were due by April 6, 2017. Federal Rule of 

Civil Procedure 72(b); Civ. Local Rule 72-3. As of today’s date, no objections have been filed. 

Having reviewed the Report and Recommendation, as well as the record in this case, I ADOPT 

Judge Corley’s Report and Recommendation in full. This case is REMANDED to Alameda 

County Superior Court for lack of jurisdiction.

IT IS SO ORDERED.

Dated: April 11, 2017

William H. Orrick

United States District Judge
VAN FLEET INTERNATIONAL AIRPORT DEVELOPMENT GROUP, LLC, petitioner, v. MOSAIC FERTILIZER, LLC.

No. 12-1040.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.